Oxidative stress and its significant roles in neurodegenerative diseases and cancer

International Journal of Molecular Sciences

Volumn 16, Issue 1, 2014, Pages 193-217

  Thanan, Raynoo ^a   Oikawa, Shinji ^b   Hiraku, Yusuke ^b   Ohnishi, Shiho ^c   Ma, Ning ^c   Pinlaor, Somchai ^a   Yongvanit, Puangrat ^a   Kawanishi, Shosuke ^c   Murata, Mariko ^b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Cancer; Carbonyl proteins; DNA damage; Lipid peroxidation; Neurodegenerative diseases; Oxidative stress; Oxysterol; Protein damage; Stem cells

Indexed keywords

8 NITROGUANINE; AMYLOID BETA PROTEIN; CD133 ANTIGEN; CYCLINE; DEOXYADENOSINE TRIPHOSPHATE; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; HEAT SHOCK PROTEIN 70; HERMES ANTIGEN; JANUS KINASE; NITRIC OXIDE; OXIDOPAMINE; OXYSTEROL; PROTEIN P53; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; STAT3 PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN;

BACTERIAL INFECTION; CANCER STEM CELL; DEGENERATIVE DISEASE; DNA DAMAGE; DNA METHYLATION; DOWN REGULATION; HUMAN; INFLAMMATION; LIPID OXIDATION; LIPID PEROXIDATION; NEOPLASM; NONHUMAN; OPISTHORCHIS VIVERRINI; OXIDATIVE STRESS; POINT MUTATION; PROTEIN EXPRESSION; REVIEW; SCHISTOSOMA HEMATOBIUM; UPREGULATION; VIRUS INFECTION; ANIMAL; METABOLISM;

ANIMALS; DNA DAMAGE; HUMANS; NEOPLASMS; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS;

EID: 84919789643     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms16010193     Document Type: Review

References (144)

1. Lambeth, J.D.; Kawahara, T.; Diebold, B. Regulation of nox and duox enzymatic activity and expression. Free Radic. Biol. Med. 2007, 43, 319-331.
2. Hiraku, Y.; Kawanishi, S.; Ichinose, T.; Murata, M. The role of inos-mediated DNA damage in infection-and asbestos-induced carcinogenesis. Ann. N. Y. Acad. Sci. 2010, 1203, 15-22.
3. Barrera, G. Oxidative stress and lipid peroxidation products in cancer progression and therapy. ISRN Oncol. 2012, doi:org/10.5402/2012/137289.
4. Reed, T.T. Lipid peroxidation and neurodegenerative disease. Free Radic. Biol. Med. 2011, 51, 1302-1319.
5. Del Rio, D.; Stewart, A.J.; Pellegrini, N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr. Metab. Cardiovasc. Dis. 2005, 15, 316-328.
6. Jusakul, A.; Yongvanit, P.; Loilome, W.; Namwat, N.; Kuver, R. Mechanisms of oxysterol-induced carcinogenesis. Lipids Health Dis. 2011, 10, 44.
7. Leoni, V.; Caccia, C. Oxysterols as biomarkers in neurodegenerative diseases. Chem. Phys. Lipids 2011, 164, 515-524.
8. Arca, M.; Natoli, S.; Micheletta, F.; Riggi, S.; di Angelantonio, E.; Montali, A.; Antonini, T.M.; Antonini, R.; Diczfalusy, U.; Iuliano, L. Increased plasma levels of oxysterols, in vivo markers of oxidative stress, in patients with familial combined hyperlipidemia: Reduction during atorvastatin and fenofibrate therapy. Free Radic. Biol. Med. 2007, 42, 698-705.
9. Lemaire-Ewing, S.; Prunet, C.; Montange, T.; Vejux, A.; Berthier, A.; Bessede, G.; Corcos, L.; Gambert, P.; Neel, D.; Lizard, G. Comparison of the cytotoxic, pro-oxidant and pro-inflammatory characteristics of different oxysterols. Cell Biol. Toxicol. 2005, 21, 97-114.
10. Lizard, G.; Gueldry, S.; Sordet, O.; Monier, S.; Athias, A.; Miguet, C.; Bessede, G.; Lemaire, S.; Solary, E.; Gambert, P. Glutathione is implied in the control of 7-ketocholesterol-induced apoptosis, which is associated with radical oxygen species production. FASEB J. 1998, 12, 1651-1663.
11. Yoon, J.H.; Canbay, A.E.; Werneburg, N.W.; Lee, S.P.; Gores, G.J. Oxysterols induce cyclooxygenase-2 expression in cholangiocytes: Implications for biliary tract carcinogenesis. Hepatology 2004, 39, 732-738.
12. Bjorkhem, I.; Diczfalusy, U. Oxysterols: Friends, foes, or just fellow passengers? Arterioscler. Thromb. Vasc. Biol. 2002, 22, 734-742.
13. Di Stasi, A.M.; Mallozzi, C.; Macchia, G.; Petrucci, T.C.; Minetti, M. Peroxynitrite induces tryosine nitration and modulates tyrosine phosphorylation of synaptic proteins. J. Neurochem. 1999, 73, 727-735.
14. He, K.; Nukada, H.; McMorran, P.D.; Murphy, M.P. Protein carbonyl formation and tyrosine nitration as markers of oxidative damage during ischaemia-reperfusion injury to rat sciatic nerve. Neuroscience 1999, 94, 909-916.
15. Kayali, R.; Telci, A.; Cakatay, U.; Karaca, C.; Akcay, T.; Sivas, A.; Altug, T. Oxidative protein damage parameters in plasma in chronic experimental diabetes in rats. Eur. J. Med. Res. 2003, 8, 307-312.
16. Lamb, N.J.; Gutteridge, J.M.; Baker, C.; Evans, T.W.; Quinlan, G.J. Oxidative damage to proteins of bronchoalveolar lavage fluid in patients with acute respiratory distress syndrome: Evidence for neutrophil-mediated hydroxylation, nitration, and chlorination. Crit. Care Med. 1999, 27, 1738-1744.
17. Lyall, F.; Gibson, J.L.; Greer, I.A.; Brockman, D.E.; Eis, A.L.; Myatt, L. Increased nitrotyrosine in the diabetic placenta: Evidence for oxidative stress. Diabetes Care 1998, 21, 1753-1758.
18. Dalle-Donne, I.; Giustarini, D.; Colombo, R.; Rossi, R.; Milzani, A. Protein carbonylation in human diseases. Trends Mol. Med. 2003, 9, 169-176.
19. Dalle-Donne, I.; Rossi, R.; Giustarini, D.; Milzani, A.; Colombo, R. Protein carbonyl groups as biomarkers of oxidative stress. Clin. Chim. Acta 2003, 329, 23-38.
20. Vistoli, G.; de Maddis, D.; Cipak, A.; Zarkovic, N.; Carini, M.; Aldini, G. Advanced glycoxidation and lipoxidation end products (ages and ales): An overview of their mechanisms of formation. Free Radic. Res. 2013, 47 (Suppl. 1), 3-27.
21. Nystrom, T. Role of oxidative carbonylation in protein quality control and senescence. EMBO J. 2005, 24, 1311-1317.
22. Dalle-Donne, I.; Aldini, G.; Carini, M.; Colombo, R.; Rossi, R.; Milzani, A. Protein carbonylation, cellular dysfunction, and disease progression. J. Cell. Mol. Med. 2006, 10, 389-406.
23. Levine, R.L.; Garland, D.; Oliver, C.N.; Amici, A.; Climent, I.; Lenz, A.G.; Ahn, B.W.; Shaltiel, S.; Stadtman, E.R. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990, 186, 464-478.
24. Nakamura, A.; Goto, S. Analysis of protein carbonyls with 2,4-dinitrophenyl hydrazine and its antibodies by immunoblot in two-dimensional gel electrophoresis. J. Biochem. 1996, 119, 768-774.
25. Oikawa, S.; Kobayashi, H.; Kitamura, Y.; Zhu, H.; Obata, K.; Minabe, Y.; Dazortsava, M.; Ohashi, K.; Tada-Oikawa, S.; Takahashi, H., et al. Proteomic analysis of carbonylated proteins in the monkey substantia nigra after ischemia-reperfusion. Free Radic. Res. 2014, 48, 694-705.
26. Oikawa, S.; Yamada, T.; Minohata, T.; Kobayashi, H.; Furukawa, A.; Tada-Oikawa, S.; Hiraku, Y.; Murata, M.; Kikuchi, M.; Yamashima, T. Proteomic identification of carbonylated proteins in the monkey hippocampus after ischemia-reperfusion. Free Radic. Biol. Med. 2009, 46, 1472-1477.
27. Thanan, R.; Oikawa, S.; Yongvanit, P.; Hiraku, Y.; Ma, N.; Pinlaor, S.; Pairojkul, C.; Wongkham, C.; Sripa, B.; Khuntikeo, N., et al. Inflammation-induced protein carbonylation contributes to poor prognosis for cholangiocarcinoma. Free Radic. Biol. Med. 2012, 52, 1465-1472.
28. Aldini, G.; Regazzoni, L.; Orioli, M.; Rimoldi, I.; Facino, R.M.; Carini, M. A tandem ms precursor-ion scan approach to identify variable covalent modification of albumin cys34: A new tool for studying vascular carbonylation. J. Mass Spectrom. 2008, 43, 1470-1481.
29. Guo, J.; Prokai, L. To tag or not to tag: A comparative evaluation of immunoaffinity-labeling and tandem mass spectrometry for the identification and localization of posttranslational protein carbonylation by 4-hydroxy-2-nonenal, an end-product of lipid peroxidation. J. Proteomics 2011, 74, 2360-2369.
30. Meany, D.L.; Xie, H.; Thompson, L.V.; Arriaga, E.A.; Griffin, T.J. Identification of carbonylated proteins from enriched rat skeletal muscle mitochondria using affinity chromatography-stable isotope labeling and tandem mass spectrometry. Proteomics 2007, 7, 1150-1163.
31. Mirzaei, H.; Regnier, F. Affinity chromatographic selection of carbonylated proteins followed by identification of oxidation sites using tandem mass spectrometry. Anal. Chem. 2005, 77, 2386-2392.
32. Rauniyar, N.; Prokai-Tatrai, K.; Prokai, L. Identification of carbonylation sites in apomyoglobin after exposure to 4-hydroxy-2-nonenal by solid-phase enrichment and liquid chromatography-electrospray ionization tandem mass spectrometry. J. Mass Spectrom. 2010, 45, 398-410.
33. Kryston, T.B.; Georgiev, A.B.; Pissis, P.; Georgakilas, A.G. Role of oxidative stress and DNA damage in human carcinogenesis. Mutat. Res. 2011, 711, 193-201.
34. Cadet, J.; Ravanat, J.L.; TavernaPorro, M.; Menoni, H.; Angelov, D. Oxidatively generated complex DNA damage: Tandem and clustered lesions. Cancer Lett. 2012, 327, 5-15.
35. Cadet, J.; Wagner, J.R. Oxidatively generated base damage to cellular DNA by hydroxyl radical and one-electron oxidants: Similarities and differences. Arch. Biochem. Biophys. 2014, 557, 47-54.
36. Brochier, C.; Langley, B. Chromatin modifications associated with DNA double-strand breaks repair as potential targets for neurological diseases. Neurotherapeutics 2013, 10, 817-830.
37. Kawanishi, S.; Hiraku, Y.; Oikawa, S. Mechanism of guanine-specific DNA damage by oxidative stress and its role in carcinogenesis and aging. Mutat. Res. 2001, 488, 65-76.
38. Ohshima, H.; Tatemichi, M.; Sawa, T. Chemical basis of inflammation-induced carcinogenesis. Arch. Biochem. Biophys. 2003, 417, 3-11.
39. Olinski, R.; Rozalski, R.; Gackowski, D.; Foksinski, M.; Siomek, A.; Cooke, M.S. Urinary measurement of 8-oxodg, 8-oxogua, and 5HMUra: A noninvasive assessment of oxidative damage to DNA. Antioxid. Redox Signal. 2006, 8, 1011-1019.
40. Cooke, M.S.; Olinski, R.; Loft, S. Measurement and meaning of oxidatively modified DNA lesions in urine. Cancer Epidemiol. Biomark. Prev. 2008, 17, 3-14.
41. Akaike, T.; Fujii, S.; Kato, A.; Yoshitake, J.; Miyamoto, Y.; Sawa, T.; Okamoto, S.; Suga, M.; Asakawa, M.; Nagai, Y., et al. Viral mutation accelerated by nitric oxide production during infection in vivo. FASEB J. 2000, 14, 1447-1454.
42. Halliwell, B. Oxygen and nitrogen are pro-carcinogens: Damage to DNA by reactive oxygen, chlorine and nitrogen species: Measurement, mechanism and the effects of nutrition. Mutat. Res. 1999, 443, 37-52.
43. Yermilov, V.; Rubio, J.; Becchi, M.; Friesen, M.D.; Pignatelli, B.; Ohshima, H. Formation of 8-nitroguanine by the reaction of guanine with peroxynitrite in vitro. Carcinogenesis 1995, 16, 2045-2050.
44. Masuda, M.; Nishino, H.; Ohshima, H. Formation of 8-nitroguanosine in cellular RNA as a biomarker of exposure to reactive nitrogen species. Chem. Biol. Interact. 2002, 139, 187-197.
45. Ma, N.; Adachi, Y.; Hiraku, Y.; Horiki, N.; Horiike, S.; Imoto, I.; Pinlaor, S.; Murata, M.; Semba, R.; Kawanishi, S. Accumulation of 8-nitroguanine in human gastric epithelium induced by helicobacter pylori infection. Biochem. Biophys. Res. Commun. 2004, 319, 506-510.
46. Sawa, T.; Tatemichi, M.; Akaike, T.; Barbin, A.; Ohshima, H. Analysis of urinary 8-nitroguanine, a marker of nitrative nucleic acid damage, by high-performance liquid chromatography-electrochemical detection coupled with immunoaffinity purification: Association with cigarette smoking. Free Radic. Biol. Med. 2006, 40, 711-720.
47. Nash, H.M.; Bruner, S.D.; Scharer, O.D.; Kawate, T.; Addona, T.A.; Spooner, E.; Lane, W.S.; Verdine, G.L. Cloning of a yeast 8-oxoguanine DNA glycosylase reveals the existence of a base-excision DNA-repair protein superfamily. Curr. Biol. 1996, 6, 968-980.
48. Earley, M.C.; Crouse, G.F. The role of mismatch repair in the prevention of base pair mutations in saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 1998, 95, 15487-15491.
49. Ni, T.T.; Marsischky, G.T.; Kolodner, R.D. MSH2 and MSH6 are required for removal of adenine misincorporated opposite 8-oxo-Guanine in S. cerevisiae. Mol. Cell 1999, 4, 439-444.
50. Reardon, J.T.; Bessho, T.; Kung, H.C.; Bolton, P.H.; Sancar, A. In vitro repair of oxidative DNA damage by human nucleotide excision repair system: Possible explanation for neurodegeneration in xeroderma pigmentosum patients. Proc. Natl. Acad. Sci. USA 1997, 94, 9463-9468.
51. Rodriguez, G.P.; Song, J.B.; Crouse, G.F. In vivo bypass of 8-oxodG. PLoS Genet. 2013, 9, e1003682.
52. Jeppesen, D.K.; Bohr, V.A.; Stevnsner, T. DNA repair deficiency in neurodegeneration. Progress Neurobiol. 2011, 94, 166-200.
53. Melis, J.P.; van Steeg, H.; Luijten, M. Oxidative DNA damage and nucleotide excision repair. Antioxid. Redox Signal. 2013, 18, 2409-2419.
54. Bruner, S.D.; Norman, D.P.; Verdine, G.L. Structural basis for recognition and repair of the endogenous mutagen 8-oxoguanine in DNA. Nature 2000, 403, 859-866.
55. Yermilov, V.; Rubio, J.; Ohshima, H. Formation of 8-nitroguanine in DNA treated with peroxynitrite in vitro and its rapid removal from DNA by depurination. FEBS Lett. 1995, 376, 207-210.
56. Loeb, L.A.; Preston, B.D. Mutagenesis by apurinic/apyrimidinic sites. Annu. Rev. Genet. 1986, 20, 201-230.
57. Suzuki, N.; Yasui, M.; Geacintov, N.E.; Shafirovich, V.; Shibutani, S. Miscoding events during DNA synthesis past the nitration-damaged base 8-nitroguanine. Biochemistry 2005, 44, 9238-9245.
58. Haracska, L.; Unk, I.; Johnson, R.E.; Johansson, E.; Burgers, P.M.; Prakash, S.; Prakash, L. Roles of yeast DNA polymerases δ and ζ and of Rev1 in the bypass of abasic sites. Genes Dev. 2001, 15, 945-954.
59. Wu, X.; Takenaka, K.; Sonoda, E.; Hochegger, H.; Kawanishi, S.; Kawamoto, T.; Takeda, S.; Yamazoe, M. Critical roles for polymerase ζ in cellular tolerance to nitric oxide-induced DNA damage. Cancer Res. 2006, 66, 748-754.
60. Chan-On, W.; Nairismagi, M.L.; Ong, C.K.; Lim, W.K.; Dima, S.; Pairojkul, C.; Lim, K.H.; McPherson, J.R.; Cutcutache, I.; Heng, H.L., et al. Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers. Nat. Genet. 2013, 45, 1474-1478.
61. Urosevic, N.; Krtolica, K.; Skaro-Milic, A.; Knezevic-Usaj, S.; Dujic, A. Prevalence of G-to-T transversions among K-ras oncogene mutations in human colorectal tumors in Yugoslavia. Int. J. Cancer 1993, 54, 249-254.
62. Hainaut, P.; Pfeifer, G.P. Patterns of p53 G→T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke. Carcinogenesis 2001, 22, 367-374.
63. Subczynski, W.K.; Hyde, J.S. Concentration of oxygen in lipid bilayers using a spin-label method. Biophys. J. 1983, 41, 283-286.
64. Bjorkhem, I.; Cedazo-Minguez, A.; Leoni, V.; Meaney, S. Oxysterols and neurodegenerative diseases. Mol. Asp. Med. 2009, 30, 171-179.
65. Lund, E.G.; Guileyardo, J.M.; Russell, D.W. Cdna cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc. Natl. Acad. Sci. USA 1999, 96, 7238-7243.
66. Wood, W.G.; Li, L.; Muller, W.E.; Eckert, G.P. Cholesterol as a causative factor in Alzheimer’s disease: A debatable hypothesis. J. Neurochem. 2014, 129, 559-572.
67. Huang, Z.; Ichihara, S.; Oikawa, S.; Chang, J.; Zhang, L.; Takahashi, M.; Subramanian, K.; Mohideen, S.S.; Wang, Y.; Ichihara, G. Proteomic analysis of hippocampal proteins of F344 rats exposed to 1-bromopropane. Toxicol. Appl. Pharmacol. 2011, 257, 93-101.
68. Moskovitz, J.; Yim, M.B.; Chock, P.B. Free radicals and disease. Arch. Biochem. Biophys. 2002, 397, 354-359.
69. Reeg, S.; Grune, T. Protein oxidation in aging: Does it play a role in aging progression? Antioxid. Redox Signal. 2014, doi:10.1089/ars.2014.6062.
70. Surgucheva, I.; Newell, K.L.; Burns, J.; Surguchov, A. New α-and γ-synuclein immunopathological lesions in human brain. Acta Neuropathol. Commun. 2014, 2, 132.
71. Picklo, M.J.; Montine, T.J.; Amarnath, V.; Neely, M.D. Carbonyl toxicology and Alzheimer’s disease. Toxicol. Appl. Pharmacol. 2002, 184, 187-197.
72. Martinez, A.; Portero-Otin, M.; Pamplona, R.; Ferrer, I. Protein targets of oxidative damage in human neurodegenerative diseases with abnormal protein aggregates. Brain Pathol. 2010, 20, 281-297.
73. Furukawa, A.; Kawamoto, Y.; Chiba, Y.; Takei, S.; Hasegawa-Ishii, S.; Kawamura, N.; Yoshikawa, K.; Hosokawa, M.; Oikawa, S.; Kato, M., et al. Proteomic identification of hippocampal proteins vulnerable to oxidative stress in excitotoxin-induced acute neuronal injury. Neurobiol. Dis. 2011, 43, 706-714.
74. Yamashima, T.; Oikawa, S. The role of lysosomal rupture in neuronal death. Progress Neurobiol. 2009, 89, 343-358.
75. Brasnjevic, I.; Hof, P.R.; Steinbusch, H.W.; Schmitz, C. Accumulation of nuclear DNA damage or neuron loss: Molecular basis for a new approach to understanding selective neuronal vulnerability in neurodegenerative diseases. DNA Repair 2008, 7, 1087-1097.
76. Madabhushi, R.; Pan, L.; Tsai, L.H. DNA damage and its links to neurodegeneration. Neuron 2014, 83, 266-282.
77. Mitra, J.; Guerrero, E.N.; Hegde, P.M.; Wang, H.; Boldogh, I.; Rao, K.S.; Mitra, S.; Hegde, M.L. New perspectives on oxidized genome damage and repair inhibition by pro-oxidant metals in neurological diseases. Biomolecules 2014, 4, 678-703.
78. Halliwell, B. The wanderings of a free radical. Free Radic. Biol. Med. 2009, 46, 531-542.
79. Oikawa, S.; Hirosawa, I.; Tada-Oikawa, S.; Furukawa, A.; Nishiura, K.; Kawanishi, S. Mechanism for manganese enhancement of dopamine-induced oxidative DNA damage and neuronal cell death. Free Radic. Biol. Med. 2006, 41, 748-756.
80. Kobayashi, H.; Oikawa, S.; Umemura, S.; Hirosawa, I.; Kawanishi, S. Mechanism of metal-mediated DNA damage and apoptosis induced by 6-hydroxydopamine in neuroblastoma SH-SY5Y cells. Free Radic. Res. 2008, 42, 651-660.
81. Piao, F.; Ma, N.; Hiraku, Y.; Murata, M.; Oikawa, S.; Cheng, F.; Zhong, L.; Yamauchi, T.; Kawanishi, S.; Yokoyama, K. Oxidative DNA damage in relation to neurotoxicity in the brain of mice exposed to arsenic at environmentally relevant levels. J. Occup. Health 2005, 47, 445-449.
82. Butterfield, D.A.; Kanski, J. Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins. Mech. Ageing Dev. 2001, 122, 945-962.
83. Hands, S.; Sajjad, M.U.; Newton, M.J.; Wyttenbach, A. In vitro and in vivo aggregation of a fragment of huntingtin protein directly causes free radical production. J. Biol. Chem. 2011, 286, 44512-44520.
84. Dechakhamphu, S.; Pinlaor, S.; Sitthithaworn, P.; Nair, J.; Bartsch, H.; Yongvanit, P. Lipid peroxidation and etheno DNA adducts in white blood cells of liver fluke-infected patients: Protection by plasma α-tocopherol and praziquantel. Cancer Epidemiol. Biomark. Prev. 2010, 19, 310-318.
85. Dechakhamphu, S.; Yongvanit, P.; Nair, J.; Pinlaor, S.; Sitthithaworn, P.; Bartsch, H. High excretion of etheno adducts in liver fluke-infected patients: Protection by praziquantel against DNA damage. Cancer Epidemiol. Biomark. Prev. 2008, 17, 1658-1664.
86. Dechakhamphu, S.; Pinlaor, S.; Sitthithaworn, P.; Bartsch, H.; Yongvanit, P. Accumulation of miscoding etheno-DNA adducts and highly expressed DNA repair during liver fluke-induced cholangiocarcinogenesis in hamsters. Mutat. Res. 2010, 691, 9-16.
87. Loilome, W.; Wechagama, P.; Namwat, N.; Jusakul, A.; Sripa, B.; Miwa, M.; Kuver, R.; Yongvanit, P. Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: A potential molecular marker for tumor metastasis. Parasitol. Int. 2012, 61, 136-139.
88. Jusakul, A.; Loilome, W.; Namwat, N.; Haigh, W.G.; Kuver, R.; Dechakhamphu, S.; Sukontawarin, P.; Pinlaor, S.; Lee, S.P.; Yongvanit, P. Liver fluke-induced hepatic oxysterols stimulate DNA damage and apoptosis in cultured human cholangiocytes. Mutat. Res. 2012, 731, 48-57.
89. Jusakul, A.; Loilome, W.; Namwat, N.; Techasen, A.; Kuver, R.; Ioannou, G.N.; Savard, C.; Haigh, W.G.; Yongvanit, P. Anti-apoptotic phenotypes of cholestan-3β,5α,6β-triol-resistant human cholangiocytes: Characteristics contributing to the genesis of cholangiocarcinoma. J. Steroid Biochem. Mol. Biol. 2013, 138, 368-375.
90. Manucha, W.; Valles, P. Hsp70/nitric oxide relationship in apoptotic modulation during obstructive nephropathy. Cell Stress Chaperones 2008, 13, 413-420.
91. Gettins, P.G. Serpin structure, mechanism, and function. Chem. Rev. 2002, 102, 4751-4804.
92. Masson, V. Roles of serine proteases and matrix metalloproteinases in tumor invasion and angiogenesis. Bull. Mem. Acad. R. Med. Belg. 2006, 161, 320-326.
93. Jamnongkan, W.; Techasen, A.; Thanan, R.; Duenngai, K.; Sithithaworn, P.; Mairiang, E.; Loilome, W.; Namwat, N.; Pairojkul, C.; Yongvanit, P. Oxidized α-1 antitrypsin as a predictive risk marker of opisthorchiasis-associated cholangiocarcinoma. Tumor Biol. 2013, 34, 695-704.
94. Mannello, F.; Tonti, G.A.; Medda, V. Protein oxidation in breast microenvironment: Nipple aspirate fluid collected from breast cancer women contains increased protein carbonyl concentration. Cell. Oncol. 2009, 31, 383-392.
95. Rossner, P., Jr.; Terry, M.B.; Gammon, M.D.; Agrawal, M.; Zhang, F.F.; Ferris, J.S.; Teitelbaum, S.L.; Eng, S.M.; Gaudet, M.M.; Neugut, A.I., et al. Plasma protein carbonyl levels and breast cancer risk. J. Cell. Mol. Med. 2007, 11, 1138-1148.
96. Zipprich, J.; Terry, M.B.; Liao, Y.; Agrawal, M.; Gurvich, I.; Senie, R.; Santella, R.M. Plasma protein carbonyls and breast cancer risk in sisters discordant for breast cancer from the new york site of the breast cancer family registry. Cancer Res. 2009, 69, 2966-2972.
97. Murata, M.; Thanan, R.; Ma, N.; Kawanishi, S. Role of nitrative and oxidative DNA damage in inflammation-related carcinogenesis. J. Biomed. Biotechnol. 2012, doi:10.1155/2012/623019.
98. Ma, N.; Thanan, R.; Kobayashi, H.; Hammam, O.; Wishahi, M.; el Leithy, T.; Hiraku, Y.; Amro el, K.; Oikawa, S.; Ohnishi, S., et al. Nitrative DNA damage and Oct3/4 expression in urinary bladder cancer with Schistosoma haematobium infection. Biochem. Biophys. Res. Commun. 2011, 414, 344-349.
99. Yongvanit, P.; Pinlaor, S.; Bartsch, H. Oxidative and nitrative DNA damage: Key events in opisthorchiasis-induced carcinogenesis. Parasitol. Int. 2012, 61, 130-135.
100. Thanan, R.; Murata, M.; Pinlaor, S.; Sithithaworn, P.; Khuntikeo, N.; Tangkanakul, W.; Hiraku, Y.; Oikawa, S.; Yongvanit, P.; Kawanishi, S. Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine in patients with parasite infection and effect of antiparasitic drug in relation to cholangiocarcinogenesis. Cancer Epidemiol. Biomark. Prev. 2008, 17, 518-524.
101. Peek, R.M., Jr.; Blaser, M.J. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer 2002, 2, 28-37.
102. Hiraku, Y.; Tabata, T.; Ma, N.; Murata, M.; Ding, X.; Kawanishi, S. Nitrative and oxidative DNA damage in cervical intraepithelial neoplasia associated with human papilloma virus infection. Cancer Sci. 2007, 98, 964-972.
103. Huang, Y.J.; Zhang, B.B.; Ma, N.; Murata, M.; Tang, A.Z.; Huang, G.W. Nitrative and oxidative DNA damage as potential survival biomarkers for nasopharyngeal carcinoma. Med. Oncol. 2011, 28, 377-384.
104. Ma, N.; Kawanishi, M.; Hiraku, Y.; Murata, M.; Huang, G.W.; Huang, Y.; Luo, D.Z.; Mo, W.G.; Fukui, Y.; Kawanishi, S. Reactive nitrogen species-dependent DNA damage in ebv-associated nasopharyngeal carcinoma: The relation to stat3 activation and egfr expression. Int. J. Cancer 2008, 122, 2517-2525.
105. Fujita, N.; Horiike, S.; Sugimoto, R.; Tanaka, H.; Iwasa, M.; Kobayashi, Y.; Hasegawa, K.; Ma, N.; Kawanishi, S.; Adachi, Y., et al. Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis c patients. Free Radic. Biol. Med. 2007, 42, 353-362.
106. Tanaka, H.; Fujita, N.; Sugimoto, R.; Urawa, N.; Horiike, S.; Kobayashi, Y.; Iwasa, M.; Ma, N.; Kawanishi, S.; Watanabe, S., et al. Hepatic oxidative DNA damage is associated with increased risk for hepatocellular carcinoma in chronic hepatitis c. Br. J. Cancer 2008, 98, 580-586.
107. Thanan, R.; Pairojkul, C.; Pinlaor, S.; Khuntikeo, N.; Wongkham, C.; Sripa, B.; Ma, N.; Vaeteewoottacharn, K.; Furukawa, A.; Kobayashi, H., et al. Inflammation-related DNA damage and expression of CD133 and Oct3/4 in cholangiocarcinoma patients with poor prognosis. Free Radic. Biol. Med. 2013, 65, 1464-1472.
108. IARC. IARC Mongraphs on the Evalution of Carcinogenic Risk to Humans; World Health Organization: Geneva, Switzerland, 2012; Volume 100; pp. 219-309.
109. Hiraku, Y.; Sakai, K.; Shibata, E.; Kamijima, M.; Hisanaga, N.; Ma, N.; Kawanishi, S.; Murata, M. Formation of the nitrative DNA lesion 8-nitroguanine is associated with asbestos contents in human lung tissues: A pilot study. J. Occup. Health 2014, 56, 186-196.
110. Scully, C.; Beyli, M.; Ferreiro, M.C.; Ficarra, G.; Gill, Y.; Griffiths, M.; Holmstrup, P.; Mutlu, S.; Porter, S.; Wray, D. Update on oral lichen planus: Etiopathogenesis and management. Crit. Rev. Oral. Biol. Med. 1998, 9, 86-122.
111. Mignogna, M.D.; Fedele, S.; Lo Russo, L.; Lo Muzio, L.; Bucci, E. Immune activation and chronic inflammation as the cause of malignancy in oral lichen planus: Is there any evidence ? Oral. Oncol. 2004, 40, 120-130.
112. Chaiyarit, P.; Ma, N.; Hiraku, Y.; Pinlaor, S.; Yongvanit, P.; Jintakanon, D.; Murata, M.; Oikawa, S.; Kawanishi, S. Nitrative and oxidative DNA damage in oral lichen planus in relation to human oral carcinogenesis. Cancer Sci. 2005, 96, 553-559.
113. Ma, N.; Tagawa, T.; Hiraku, Y.; Murata, M.; Ding, X.; Kawanishi, S. 8-Nitroguanine formation in oral leukoplakia, a premalignant lesion. Nitric Oxide 2006, 14, 137-143.
114. Ekbom, A.; Helmick, C.; Zack, M.; Adami, H.O. Increased risk of large-bowel cancer in Crohn’s disease with colonic involvement. Lancet 1990, 336, 357-359.
115. Ding, X.; Hiraku, Y.; Ma, N.; Kato, T.; Saito, K.; Nagahama, M.; Semba, R.; Kuribayashi, K.; Kawanishi, S. Inducible nitric oxide synthase-dependent DNA damage in mouse model of inflammatory bowel disease. Cancer Sci. 2005, 96, 157-163.
116. Hoki, Y.; Hiraku, Y.; Ma, N.; Murata, M.; Matsumine, A.; Nagahama, M.; Shintani, K.; Uchida, A.; Kawanishi, S. Inos-dependent DNA damage in patients with malignant fibrous histiocytoma in relation to prognosis. Cancer Sci. 2007, 98, 163-168.
117. Alison, M.R. Liver stem cells: Implications for hepatocarcinogenesis. Stem Cell Rev. 2005, 1, 253-260.
118. Maitland, N.J.; Collins, A.T. Inflammation as the primary aetiological agent of human prostate cancer: A stem cell connection? J. Cell Biochem. 2008, 105, 931-939.
119. Shipitsin, M.; Polyak, K. The cancer stem cell hypothesis: In search of definitions, markers, and relevance. Lab. Investig. 2008, 88, 459-463.
120. Reya, T.; Morrison, S.J.; Clarke, M.F.; Weissman, I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414, 105-111.
121. Ohnishi, S.; Ma, N.; Thanan, R.; Pinlaor, S.; Hammam, O.; Murata, M.; Kawanishi, S. DNA damage in inflammation-related carcinogenesis and cancer stem cells. Oxid. Med. Cell. Longev. 2014, 2013, 387014.
122. Thanan, R.; Murata, M.; Ma, N.; Hammam, O.; Wishahi, M.; El Leithy, T.; Hiraku, Y.; Oikawa, S.; Kawanishi, S. Nuclear localization of COX-2 in relation to the expression of stemness markers in urinary bladder cancer. Mediat. Inflamm. 2012, doi.org/10.1155/2012/165879.
123. Croker, A.K.; Allan, A.L. Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cells. Breast Cancer Res. Treat. 2012, 133, 75-87.
124. Guo, Y.; Einhorn, L.; Kelley, M.; Hirota, K.; Yodoi, J.; Reinbold, R.; Scholer, H.; Ramsey, H.; Hromas, R. Redox regulation of the embryonic stem cell transcription factor Oct-4 by thioredoxin. Stem Cells 2004, 22, 259-264.
125. Ishimoto, T.; Nagano, O.; Yae, T.; Tamada, M.; Motohara, T.; Oshima, H.; Oshima, M.; Ikeda, T.; Asaba, R.; Yagi, H., et al. CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc− and thereby promotes tumor growth. Cancer Cell 2011, 19, 387-400.
126. Shi, X.; Zhang, Y.; Zheng, J.; Pan, J. Reactive oxygen species in cancer stem cells. Antioxid. Redox Signal. 2012, 16, 1215-1228.
127. Hitchler, M.J.; Domann, F.E. An epigenetic perspective on the free radical theory of development. Free Radic. Biol. Med. 2007, 43, 1023-1036.
128. Franco, R.; Schoneveld, O.; Georgakilas, A.G.; Panayiotidis, M.I. Oxidative stress, DNA methylation and carcinogenesis. Cancer Lett. 2008, 266, 6-11.
129. Laget, S.; Miotto, B.; Chin, H.G.; Esteve, P.O.; Roberts, R.J.; Pradhan, S.; Defossez, P.A. MBD4 cooperates with DNMT1 to mediate methyl-DNA repression and protects mammalian cells from oxidative stress. Epigenetics 2014, 9, 546-556.
130. Soberanes, S.; Gonzalez, A.; Urich, D.; Chiarella, S.E.; Radigan, K.A.; Osornio-Vargas, A.; Joseph, J.; Kalyanaraman, B.; Ridge, K.M.; Chandel, N.S., et al. Particulate matter air pollution induces hypermethylation of the p16 promoter via a mitochondrial ROS-JNK-DNMT1 pathway. Sci. Rep. 2012, doi:10.1038/srep00275.
131. Hodge, D.R.; Cho, E.; Copeland, T.D.; Guszczynski, T.; Yang, E.; Seth, A.K.; Farrar, W.L. IL-6 enhances the nuclear translocation of DNA cytosine-5-methyltransferase 1 (DNMT1) via phosphorylation of the nuclear localization sequence by the AKT kinase. Cancer Genomics Proteomics 2007, 4, 387-398.
132. Li, Y.; Deuring, J.; Peppelenbosch, M.P.; Kuipers, E.J.; de Haar, C.; van der Woude, C.J. IL-6-induced DNMT1 activity mediates SOCS3 promoter hypermethylation in ulcerative colitis-related colorectal cancer. Carcinogenesis 2012, 33, 1889-1896.
133. Thaler, R.; Agsten, M.; Spitzer, S.; Paschalis, E.P.; Karlic, H.; Klaushofer, K.; Varga, F. Homocysteine suppresses the expression of the collagen cross-linker lysyl oxidase involving IL-6, Fli1, and epigenetic DNA methylation. J. Biol. Chem. 2007, 286, 5578-5588.
134. Niller, H.H.; Wolf, H.; Minarovits, J. Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia. Semin. Cancer Biol. 2009, 19, 158-164.
135. Chen, F.; Mo, Y.; Ding, H.; Xiao, X.; Wang, S.Y.; Huang, G.; Zhang, Z.; Wang, S.Z. Frequent epigenetic inactivation of Myocardin in human nasopharyngeal carcinoma. Head Neck 2011, 33, 54-59.
136. Du, C.; Huang, T.; Sun, D.; Mo, Y.; Feng, H.; Zhou, X.; Xiao, X.; Yu, N.; Hou, B.; Huang, G., et al. CDH4 as a novel putative tumor suppressor gene epigenetically silenced by promoter hypermethylation in nasopharyngeal carcinoma. Cancer Lett. 2011, 309, 54-61.
137. Mo, Y.; Midorikawa, K.; Zhang, Z.; Zhou, X.; Ma, N.; Huang, G.; Hiraku, Y.; Oikawa, S.; Murata, M. Promoter hypermethylation of Ras-related GTPase gene RRAD inactivates a tumor suppressor function in nasopharyngeal carcinoma. Cancer Lett. 2012, 323, 147-154.
138. Wang, S.; Xiao, X.; Zhou, X.; Huang, T.; Du, C.; Yu, N.; Mo, Y.; Lin, L.; Zhang, J.; Ma, N., et al. TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma. BMC Cancer 2010, 10, 617.
139. Zhang, Z.; Sun, D.; van, D. N.; Tang, A.; Hu, L.; Huang, G. Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma. Int. J. Cancer 2007, 120, 32-38.
140. Pizza, V.; Agresta, A.; D’Acunto, C.W.; Festa, M.; Capasso, A. Neuroinflammation and ageing: Current theories and an overview of the data. Rev. Recent Clin. Trials 2011, 6, 189-203.
141. Aseervatham, G.S.; Sivasudha, T.; Jeyadevi, R.; Arul Ananth, D. Environmental factors and unhealthy lifestyle influence oxidative stress in humans—An overview. Environ. Sci. Pollut. Res. Int. 2013, 20, 4356-4369.
142. Mylonas, C.; Kouretas, D. Lipid peroxidation and tissue damage. In Vivo (Athens, Greece) 1999, 13, 295-309.
143. Giordano, S.; Darley-Usmar, V.; Zhang, J. Autophagy as an essential cellular antioxidant pathway in neurodegenerative disease. Redox Biol. 2014, 2, 82-90.
144. Driver, J.A. Inverse association between cancer and neurodegenerative disease: Review of the epidemiologic and biological evidence. Biogerontology 2014, 15, 547-557.